Home > Boards > US Listed > Biotechs > Compugen (CGEN)

I sold a bit on that peak at

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
shub Member Profile
 
Followed By 12
Posts 1,387
Boards Moderated 0
Alias Born 04/12/11
160x600 placeholder
Compugen EPS in-line Seeking Alpha - 2/25/2021 7:09:37 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 2/25/2021 7:07:09 AM
Compugen Q4 Earnings Preview Seeking Alpha - 2/24/2021 11:52:29 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 2/22/2021 7:07:24 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/16/2021 4:46:08 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/5/2021 6:12:38 AM
Compugen: Preclinical Milestone Met in AstraZeneca Agreement Dow Jones News - 12/23/2020 7:49:00 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 12/23/2020 7:02:35 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 12/10/2020 4:11:13 PM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 12/10/2020 4:06:32 PM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 11/5/2020 7:10:52 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 9/17/2020 8:45:53 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 9/8/2020 7:05:54 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 8/5/2020 8:56:11 AM
Securities Registration (foreign Private Issuer) (f-3) Edgar (US Regulatory) - 7/30/2020 7:19:57 AM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 7/30/2020 7:15:50 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 7/30/2020 7:03:56 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 6/1/2020 7:06:20 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/27/2020 7:06:01 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/6/2020 7:03:19 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 4/27/2020 6:09:26 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 4/15/2020 7:03:50 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 4/6/2020 7:06:04 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 3/17/2020 7:05:57 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 3/13/2020 4:11:08 PM
shub   Tuesday, 08/15/17 03:15:46 PM
Re: shub post# 158
Post # of 202 
I sold a bit on that peak at $4, and now it's settled back down so i put in a limit order to buy it back at $3.
Our big advantage in being able to identify onco-checkpoints first, is largely gone as the technology advances. But i presume that we've made significant advances ourselves and have been developing our discoverys for some time, giving us the first comer's advantage.
Initially i'd anticipated big pharma lining up outside our doors, clamoring for leads, given their own inability to produce original discoveries...But no pie. So we're going forward ourselves.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences